Cargando…
Home oxygen therapy
Long-term home oxygen therapy improves survival in patients with chronic obstructive pulmonary disease and persistent, severe hypoxaemia. It is uncertain that this benefit extends to patients with other chronic lung diseases. Oxygen is a treatment for hypoxaemia, not breathlessness. To confirm hypox...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
NPS MedicineWise
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882449/ https://www.ncbi.nlm.nih.gov/pubmed/35233135 http://dx.doi.org/10.18773/austprescr.2022.007 |
_version_ | 1784659702918938624 |
---|---|
author | McDonald, Christine F |
author_facet | McDonald, Christine F |
author_sort | McDonald, Christine F |
collection | PubMed |
description | Long-term home oxygen therapy improves survival in patients with chronic obstructive pulmonary disease and persistent, severe hypoxaemia. It is uncertain that this benefit extends to patients with other chronic lung diseases. Oxygen is a treatment for hypoxaemia, not breathlessness. To confirm hypoxaemia, blood gas analysis is recommended before prescribing oxygen. There is limited and conflicting evidence that portable oxygen for exertional use is of benefit to patients with chronic obstructive pulmonary disease who do not have severe hypoxaemia. Laboratory studies show improvements in exercise capacity and dyspnoea, but these do not translate into significant benefits in the home setting. Patients should be educated regarding the expected benefits, risks and burdens of home oxygen therapy. It is particularly important that the patient does not smoke. |
format | Online Article Text |
id | pubmed-8882449 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | NPS MedicineWise |
record_format | MEDLINE/PubMed |
spelling | pubmed-88824492022-02-28 Home oxygen therapy McDonald, Christine F Aust Prescr Article Long-term home oxygen therapy improves survival in patients with chronic obstructive pulmonary disease and persistent, severe hypoxaemia. It is uncertain that this benefit extends to patients with other chronic lung diseases. Oxygen is a treatment for hypoxaemia, not breathlessness. To confirm hypoxaemia, blood gas analysis is recommended before prescribing oxygen. There is limited and conflicting evidence that portable oxygen for exertional use is of benefit to patients with chronic obstructive pulmonary disease who do not have severe hypoxaemia. Laboratory studies show improvements in exercise capacity and dyspnoea, but these do not translate into significant benefits in the home setting. Patients should be educated regarding the expected benefits, risks and burdens of home oxygen therapy. It is particularly important that the patient does not smoke. NPS MedicineWise 2022-02-01 2022-02 /pmc/articles/PMC8882449/ /pubmed/35233135 http://dx.doi.org/10.18773/austprescr.2022.007 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License. |
spellingShingle | Article McDonald, Christine F Home oxygen therapy |
title | Home oxygen therapy |
title_full | Home oxygen therapy |
title_fullStr | Home oxygen therapy |
title_full_unstemmed | Home oxygen therapy |
title_short | Home oxygen therapy |
title_sort | home oxygen therapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882449/ https://www.ncbi.nlm.nih.gov/pubmed/35233135 http://dx.doi.org/10.18773/austprescr.2022.007 |
work_keys_str_mv | AT mcdonaldchristinef homeoxygentherapy |